This was a single-center, observational cohort study conducted at an 852-bed academic medical center. The study involved a review of electronic and paper medical records of patients who received ...
Please provide your email address to receive an email when new articles are posted on . LONDON — In patients with ACS undergoing PCI, rates of major adverse cardiac events and net adverse clinical ...
A chart review was performed for all patients who received heparin from July 1, 1999, through February 28, 2000, in an acute care hospital in Athens, Georgia. Data collected included age, sex, height, ...
A before-and-after comparison following the exclusion of heparin from continuous infusions through PICCs placed by a designated team. Duration of use was assessed during epochs immediately preceding ...
B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. Based on the new United States Pharmacopeia (USP) standards for heparin products released ...
In a randomized, double-blind trial, we compared tenecteplase plus heparin with placebo plus heparin in normotensive patients with intermediate-risk pulmonary embolism. Eligible patients had right ...
Correctly diagnosing heparin resistance in patients on extracorporeal membrane oxygenation (ECMO) is challenging. In patients with sepsis, the differential diagnosis for heparin resistance is large, ...
BARCELONA, Spain—Yet another trial has found no advantage to bivalirudin over heparin monotherapy for a composite endpoint of death from any cause, myocardial infarction, or major bleeding in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results